A validated reversed phase HPLC-method for the determination of olmesartan medoxomil in combination with hydrochlorothiazide

Saudi Pharmaceutical Journal

Volumn 17, Issue 2, 2009, Pages 189-194

  Birajdar, Arunadevi S ^a   Meyyanathan, S N ^a   Suresh, B ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Hydrochlorothiazide; Loratidine; Olmesartan medoxomil; RP HPLC

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; HYDROCHLOROTHIAZIDE; LORATADINE; OLMESARTAN; SILICON DIOXIDE;

ACCURACY; ARTICLE; CONCENTRATION RESPONSE; DRUG DETERMINATION; DRUG STRUCTURE; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 67249113538     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. The Martindale The complete drug reference. 35th ed., Lambeta high street, London SEI 75M, UK. 2006.
2. Julie AB, and John MB, Olmesartan Medoxomil: New Signs in Hypertension ,New drug ,Olmesartan medoxomil, An angiotensin II-receptor blocker. Clinical Therapeutics. 2004; 26 (1): A28-A32.
3. Celebier M and Altinoz S, Determination of olmesartan medoxomil in tablets by UV- Vis spectrophotometry. Pharmazie. 2007; 62 (6): 419-422 (Pubitemid 46975263)
4. Mustafa C, Elebier and Sacide A, Development of a CZE Method for the determination of Olmesartan Medoxomil in tablets. Chromatographia. 2007; 66: 929-933 (Pubitemid 350211964)
5. Liu D, Hu P, Matsushima N, Li X, Li L and Jiang J, Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B. 2007; 852 (1-2): 436-442
6. Fei L, Yu X, Shu, G, Jundong, Z and Qingxiang G, Determination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry. J. Pharm. Biomed. Anal. 2007; 44:1187-1191
7. Chrysant SG, and Chrysant GS, Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide. Expert Opinion on Pharmacotherapy. 2004; 5(3): 657-667 (Pubitemid 38344319)
8. Isabel A, Vicente R, Soledad G, Concepción and Sánchez-Pedreño Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry. J. Pharm. Biomed. Anal. 2002; 29: 299-305.
9. Hillaert S, and Van den Bossche, W. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 2003; 31: 329-339
10. Taomin H, Zhong He, Bei Y, Luping S, Xiaowei Z and Gengli D, Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution. J. Pharm. Biomed. Anal. 2006; 41:644-648
11. Sathe SR and Bari SB, Simultaneous analysis of losartan potassium, atenolol, and hydrochlorothiazide in bulk and in tablets by high-performance thin-layer chromatography with uv absorption densitometry. Acta chromatographica. 2007; 19: 270-278
12. Al-momani F, Determination of Hydrochlorothiazide and Enalapril Maleate in Tablet Formulations by Reversed-Phase HPLC. Turk J. Chem. 2001; 25:49-54. (Pubitemid 33232725)
13. Hao L, Yingwu W, Yao J, Yunbiao T, Jiang W, Limei Z and Jingkai G, A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. Euro. J. Pharmacology. 2003; 460 (1): 19-26.
14. Sagirli O, Öhal A, Toker SE and Sensoy D, Simultaneous HPLC Analysis of Olmesartan and Hydrochlorothiazide in Combined Tablets and in vitro Dissolution Studies. Chromatographia. 2007; 66: 213-218
15. Chen M, Zhou B and Wei D, HPLC determination of olmesartan medoxomil- hydrochlorothiazide tablets. Chinese J. New Drugs.2006; 15(23):2050-2052
16. Shah NJ, Suhagia BN, Shah RR and Petal NM, Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. Indian J. Pharm. Sci.2007; 69(6): 834-36.
17. ICH, Q2A Text on validation of analytical procedures, International Conference on Harmonization., October 1994, Geneva.
18. Validation of Analytical Procedures: Methodology, ICH Harmonized tripartite Guideline, 1996, Geneva.